AAAAAA

   
Results: 1-7 |
Results: 7
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrantnodular acne
Authors: Strauss, JS Leyden, JJ Lucky, AW Lookingbill, DP Drake, LA Hanifin, JM Lowe, NJ Jones, TM Stewart, DM Jarratt, MT Katz, I Pariser, DM Pariser, RJ Tschen, E Chalker, DK Rafal, ES Savin, RP Roth, HL Chang, LK Baginski, DJ Kempers, S McLane, J Eberhardt, D Leach, EE Bryce, G Hong, J
Citation: Js. Strauss et al., A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrantnodular acne, J AM ACAD D, 45(2), 2001, pp. 187-195
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin
Authors: Strauss, JS Leyden, JJ Lucky, AW Lookingbill, DP Drake, LA Hanifin, JM Lowe, NJ Jones, TM Stewart, DM Jarratt, MT Katz, I Pariser, DM Pariser, RJ Tschen, E Chalker, DK Rafal, ES Savin, RP Roth, HL Chang, LK Baginski, DJ Kempers, S McLane, J Hong, J Leach, EE Bryce, G Eberhardt, D
Citation: Js. Strauss et al., Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin, J AM ACAD D, 45(2), 2001, pp. 196-207
Global spread of microorganisms by ships - Ballast water discharged from vessels harbours a cocktail of potential pathogens.
Authors: Ruiz, GM Rawlings, TK Dobbs, FC Drake, LA Mullady, T Huq, A Colwell, RR
Citation: Gm. Ruiz et al., Global spread of microorganisms by ships - Ballast water discharged from vessels harbours a cocktail of potential pathogens., NATURE, 408(6808), 2000, pp. 49-50
The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life
Authors: Drake, LA Patrick, DL Fleckman, P Andre, J Baran, R Haneke, E Sapede, C Tosti, A
Citation: La. Drake et al., The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life, J AM ACAD D, 41(2), 1999, pp. 189-196
Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis
Authors: Drake, LA Cohen, L Gillies, R Flood, JG Riordan, AT Phillips, SB Stiller, MJ
Citation: La. Drake et al., Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis, J AM ACAD D, 41(2), 1999, pp. 209-214
The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis
Authors: Berberian, BJ Breneman, DL Drake, LA Gratton, D Raimir, SS Phillips, S Sulica, VI Bernstein, JE
Citation: Bj. Berberian et al., The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis, INT J DERM, 38(2), 1999, pp. 145-148
Quality of life for patients with onychomycosis
Authors: Millikan, LE Powell, DW Drake, LA
Citation: Le. Millikan et al., Quality of life for patients with onychomycosis, INT J DERM, 38, 1999, pp. 13-16
Risultati: 1-7 |